Abstract
We presented two cases of phyllodes tumor of the breast examined by99mTc-sestamibi (MIBI) two-phase scintimammography. In the case with malignant phyllodes tumor,99mTc-MIBI accumulation was recognized on both early and delayed images. In the case with benign phyllodes tumor, however,99mTc-MIBI accumulation was recognized on only the early image.99mTc-MIBI delayed imaging may have the potential to distinguish between benign and malignant phyllodes tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosen PP, Oberman HA. Cystosarcoma phyllodes.In Atlas of Tumor Pathology: Tumors of the Mammary Gland, Rosai J, Sobin LH (eds.), Washington DC, Armed Forces Institute of Pathology, pp. 107–114, 1993.
Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases.Cancer 41: 1974–1983, 1978.
Liberman L, Bonaccio E, Hamele-Bena D, Abramson AF, Cohen MA, Dershaw DD. Benign and malignant phyllodes tumors: mammographic and sonographic findings.Radiology 198: 121–124, 1996.
Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriére J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.J Nucl Med 36: 1758–1765, 1995.
Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.J Nucl Med 36: 1784–1789, 1995.
Umpleby HC, Moore I, Royle GT, Guyer PB, Taylor I. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes.Ann R Coll Surg Engl 71: 285–288, 1989.
Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts.J Nucl Med 31: 1646–1653, 1990.
Moretti JL, Caglar M, Boaziz C, Calliat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?Eur J Nucl Med 22: 177–180, 1995.
Maffioli L, Steens J, Pauwels E, Bombardieri E. Application of99mTc-sestamibi in oncology.Tumori 82: 12–21, 1996.
Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistant P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.J Nucl Med 35: 510–515, 1994.
Komori T, Matsui R, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I.In vitro uptake and release of201T1 and99mTc-MIBI in HeLa cell.KAKU IGAKU (Jpn J Nucl Med) 32: 651–658, 1995.
Lu G, Shin WJ, Huang HY, Long MQ, Sun Q, Liu YH, et al.99mTc-MIBI mammoscintigraphy of breast masses: early and delayed imaging.Nucl Med Commun 16: 150–156, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohta, H., Komibuchi, T., Nishio, T. et al. Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors. Ann Nucl Med 11, 37–39 (1997). https://doi.org/10.1007/BF03164756
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164756